Alzheimer's disease: have we got the cause all wrong?

by Vicky Jones,The ConversationCredit: Unsplash/CC0 Public DomainEarly in the 20th century,Alois Alzheimerfirst described a disorder of progressive memory loss and confusion in a 50-

Updated on: April 10,2024

Alzheimer's disease: have we got the cause all wrong?

by Vicky Jones,The ConversationCredit: Unsplash/CC0 Public DomainEarly in the 20th century,Alois Alzheimerfirst described a disorder of progressive memory loss and confusion in a 50-

Updated on:April 10,2024

Unlocking the science of sleep: How rest enhances language learning

byUniversity of South AustraliaCredit: Unsplash/CC0 Public DomainSleep is critical for all sorts of reasons, but a team of international scientists has discovered a new incentive for getting eig

Updated on: December 16,2024

Unlocking the science of sleep: How rest enhances language learning

byUniversity of South AustraliaCredit: Unsplash/CC0 Public DomainSleep is critical for all sorts of reasons, but a team of international scientists has discovered a new incentive for getting eig

Updated on:December 16,2024

Antidepressant use increases risk of head injuries among persons with Alzheimer's disease

by University of Eastern FinlandAntidepressant use is associated with an increased risk of head injuries and traumatic brain injuries among persons with Alzheimer's disease, according to a ne

Updated on: March 07,2024

Antidepressant use increases risk of head injuries among persons with Alzheimer's disease

by University of Eastern FinlandAntidepressant use is associated with an increased risk of head injuries and traumatic brain injuries among persons with Alzheimer's disease, according to a ne

Updated on:March 07,2024

Alzheimer's disease study links brain health and physical activity

by IOS PressCredit: IOS PressPeople at risk for Alzheimer's disease who do more moderate-intensity physical activity, but not light-intensity physical activity, are more likely to have health

Updated on: April 16,2024

Alzheimer's disease study links brain health and physical activity

by IOS PressCredit: IOS PressPeople at risk for Alzheimer's disease who do more moderate-intensity physical activity, but not light-intensity physical activity, are more likely to have health

Updated on:April 16,2024

FDA approves much-debated Alzheimer's drug panned by experts

by Matthew PerroneIn this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administratio

Updated on: March 30,2024

FDA approves much-debated Alzheimer's drug panned by experts

by Matthew PerroneIn this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administratio

Updated on:March 30,2024

Researchers develop combined data model to better evaluate for mild cognitive impairment

by Boston University School of MedicineA new study has shown that by combining imaging and neuropsychological testing, one can more accurately assess the cognitive status of individuals.Cognitive

Updated on: March 07,2024

Researchers develop combined data model to better evaluate for mild cognitive impairment

by Boston University School of MedicineA new study has shown that by combining imaging and neuropsychological testing, one can more accurately assess the cognitive status of individuals.Cognitive

Updated on:March 07,2024

Dementia: how to prevent cognitive decline

by University of MontrealCredit: CC0 Public DomainPhysical activity, nutrition and cognitively stimulating activities are all known to be good ways to prevent Alzheimer's disease and dementia

Updated on: May 09,2024

Dementia: how to prevent cognitive decline

by University of MontrealCredit: CC0 Public DomainPhysical activity, nutrition and cognitively stimulating activities are all known to be good ways to prevent Alzheimer's disease and dementia

Updated on:May 09,2024

Alzheimer's-disease-related proteases control axonal guidance by regulating growth cone dynamics

by VIB (the Flanders Institute for Biotechnology)Diagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.BACE1 is the major drug target for Alzheimer's

Updated on: February 26,2024

Alzheimer's-disease-related proteases control axonal guidance by regulating growth cone dynamics

by VIB (the Flanders Institute for Biotechnology)Diagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.BACE1 is the major drug target for Alzheimer's

Updated on:February 26,2024

Artificial intelligence predicts dementia before onset of symptoms

by McGill UniversityCredit: McGill UniversityImagine if doctors could determine, many years in advance, who is likely to develop dementia. Such prognostic capabilities would give patients and the

Updated on: March 09,2024

Artificial intelligence predicts dementia before onset of symptoms

by McGill UniversityCredit: McGill UniversityImagine if doctors could determine, many years in advance, who is likely to develop dementia. Such prognostic capabilities would give patients and the

Updated on:March 09,2024

Power outage in the brain may be source of Alzheimer's

by Arizona State UniversityMitochondria are membrane-bound organelles present in eukaryotic cells. Their essential role is to supply cells with energy in the form of ATP. Mitochondrial dysfunctio

Updated on: May 18,2024

Power outage in the brain may be source of Alzheimer's

by Arizona State UniversityMitochondria are membrane-bound organelles present in eukaryotic cells. Their essential role is to supply cells with energy in the form of ATP. Mitochondrial dysfunctio

Updated on:May 18,2024

FDA defends approval of controversial Alzheimer's drug

by Dennis ThompsonThe U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defendi

Updated on: March 30,2024

FDA defends approval of controversial Alzheimer's drug

by Dennis ThompsonThe U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defendi

Updated on:March 30,2024

An anti-apoE4 specific monoclonal antibody counteracts the pathological effects of apoE4 in vivo

by Bentham Science PublishersThe pathological hallmarks of Alzheimer's disease (AD), viz defective Aβ and tau proteins, have been the center of AD-directed therapeutic studies. Although this appro

Updated on: March 07,2024

An anti-apoE4 specific monoclonal antibody counteracts the pathological effects of apoE4 in vivo

by Bentham Science PublishersThe pathological hallmarks of Alzheimer's disease (AD), viz defective Aβ and tau proteins, have been the center of AD-directed therapeutic studies. Although this appro

Updated on:March 07,2024